Adagio Medical Holdings, Inc. (ADGM)
NASDAQ: ADGM · Real-Time Price · USD
2.700
-0.170 (-5.92%)
Oct 31, 2024, 4:00 PM EDT - Market closed
Adagio Medical Holdings Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 |
| Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Revenue | 0.4 | 0.3 | 0.19 |
| Revenue Growth (YoY) | - | 58.73% | - |
| Cost of Revenue | 1.81 | 1.31 | 0.88 |
| Gross Profit | -1.41 | -1.01 | -0.69 |
| Selling, General & Admin | 15.95 | 11.54 | 5.37 |
| Research & Development | 12.53 | 15.4 | 17.86 |
| Operating Expenses | 28.48 | 26.94 | 23.23 |
| Operating Income | -29.89 | -27.94 | -23.91 |
| Interest Expense | -2.58 | -1.66 | -0.14 |
| Interest & Investment Income | 0.01 | 0 | 0.04 |
| Other Non Operating Income (Expenses) | -2.34 | -8.55 | 0.34 |
| Pretax Income | -34.8 | -38.15 | -23.67 |
| Net Income | -34.8 | -38.15 | -23.67 |
| Net Income to Common | -34.8 | -38.15 | -23.67 |
| Shares Outstanding (Basic) | 1 | 1 | 1 |
| Shares Outstanding (Diluted) | 1 | 1 | 1 |
| Shares Change (YoY) | - | 1.10% | - |
| EPS (Basic) | -45.18 | -50.20 | -31.50 |
| EPS (Diluted) | -45.18 | -50.20 | -31.50 |
| Free Cash Flow | -27.65 | -25.99 | -22.9 |
| Free Cash Flow Per Share | -35.89 | -34.20 | -30.47 |
| Operating Margin | -7490.73% | -9314.00% | -12652.38% |
| Profit Margin | -8721.80% | -12715.33% | -12525.40% |
| Free Cash Flow Margin | -6929.57% | -8661.67% | -12118.52% |
| EBITDA | -29.03 | -27.41 | -23.42 |
| D&A For EBITDA | 0.86 | 0.53 | 0.5 |
| EBIT | -29.89 | -27.94 | -23.91 |
Source: S&P Capital IQ. Standard template.
Financial Sources.